Page last updated: 2024-11-08

acth (4-7)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ACTH (4-7): RN given refers to L-Phe cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID170920
MeSH IDM0094284

Synonyms (8)

Synonym
acth (4-7)
acth 4-7
corticotropin (4-7)
50842-42-7
l-phenylalanine, n-(n-(n-l-methionyl-l-alpha-glutamyl)-l-histidyl)-
DTXSID90965078
n-[2-{[2,6-diamino-4-carboxy-1-hydroxy-8-(methylsulfanyl)-5-oxooctylidene]amino}-1-hydroxy-3-(4h-imidazol-4-yl)propylidene]phenylalanine
(4s)-4-amino-2-[(2s)-2-amino-3-[[(2s)-1-[[(1s)-1-carboxy-2-phenylethyl]amino]-3-(4h-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-oxopropyl]-6-methylsulfanyl-3-oxohexanoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (90.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]